These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6429807)

  • 1. [Acquired inhibition of coagulation factor VIII].
    Figueroa H; Lira P; Grebe G; Mezzano D; Legues ME
    Rev Med Chil; 1984 Jan; 112(1):43-6. PubMed ID: 6429807
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression of patients with acquired factor VIII inhibitors.
    Green D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemorrhagic telangiectasia and factor VIII inhibitor.
    Sudarshan A; Natelson EA; Gordon C
    South Med J; 1985 May; 78(5):623-4. PubMed ID: 3922057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature].
    Bayani N; Lelong F
    Ann Med Interne (Paris); 2001 Apr; 152(3):201-8. PubMed ID: 11431582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone.
    Herbst KD; Rapaport SI; Kenoyer DG; Stanton W; Feinstein DI
    Ann Intern Med; 1981 Nov; 95(5):575-8. PubMed ID: 6794408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
    José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
    Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of autoimmune factor VIII inhibitors to a combination of cyclophosphamide and prednisone.
    Berrut G; Shoaay I; Dupuis JM; Maigre M; Fressinaud P; Fressinaud E
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):145-6. PubMed ID: 8180335
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
    Moccia F; Tognoni E; Boccaccio P
    Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
    Green D; Rademaker AW; Briët E
    Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired coagulation factor VIII inhibitor in a non-hemophiliac patient].
    Polo Romero FJ; Fernández Fúnez A
    Rev Clin Esp; 1999 Feb; 199(2):114-5. PubMed ID: 10216409
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M; Derom E; Baele G
    Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired inhibitor to factor VIII in a nonhemophiliac patient.
    Przybylinski JP; Reinhart RA
    J Am Geriatr Soc; 1986 Jun; 34(6):472-4. PubMed ID: 3084612
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
    Rizza CR; Edgcumbe JO; Pitney WR; Child JA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemarthrosis in patients with acquired factor VIII inhibitor.
    Louthrenoo W; Abrahm J; Schumacher HR
    J Rheumatol; 1991 Jan; 18(1):104-5. PubMed ID: 1902518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An idiopathic factor VIII anticoagulant: resolution following plasmapheresis and cytotoxic therapy.
    Goldsmith JC; Hamilton HE
    Am J Med Sci; 1985 Dec; 290(6):246-8. PubMed ID: 3936359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful immunosuppressive treatment of high-titer postpartum factor VII inhibitor.
    Annichino-Bizzachi JM; Machado TF; Arruda VR
    Ann Intern Med; 1993 Dec; 119(11):1149-50. PubMed ID: 8239240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.